Scientists under the leadership of Peter Loskill from NMI and University of Tübingen have invented a new technique improving the research on a molecular and cellular level in the pancreas, which can potentially advance diabetes drug development.
Originamitteilung:
More than seven million people in Germany suffer from diabetes. Drug research is still difficult. Scientists led by Peter Loskill from the NMI and the University of Tübingen have developed a technique that significantly improves the view on the molecular and cell biological level in the pancreas.